COntinue the SaMe Systemic Therapy After Local Ablative Therapy for Oligo Progression in Metastatic Breast Cancer - the COSMO Study
COntinue the SaMe Systemic Therapy After Local Ablative Therapy for Oligo Progression in Metastatic Breast Cancer - the COSMO Study
Recruiting · NCT05301881 · Registry updated 2026-09-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| COntinue the SaMe Systemic Therapy After Local Ablative Therapy for Oligo Progression in Metastatic Breast Cancer - the COSMO Study | Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, metastatic malignant neoplasm, neoplasm | Recruiting | Phase 2 | 2026-09-11 | NCT05301881 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Maarten van de Weijden Foundation | 2 |
| The Netherlands Cancer Institute | 113 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| ADRZ | Goes | Netherlands | 1 |
| Antoni van Leeuwenhoek | Amsterdam | Netherlands | 20 |
| Antonius ziekenhuis | Utrecht | Netherlands | 2 |
| Deventer Ziekenhuis | Deventer | Netherlands | 21 |
| Martini Ziekenhuis | Groningen | Netherlands | 23 |
| Noordwest Ziekenhuisgroep | Alkmaar | Netherlands | 21 |
| Rijnstate | Arnhem | Netherlands | 19 |